Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H Drew

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Managed Care Pharmacy : JMCP|February 25, 2009
Antimicrobial stewardship programs: how to start and steer a successful programRichard H Drew
The Annals of Pharmacotherapy|March 29, 2007
Could risk assessment for non-albicans Candida improve empiric treatment for invasive candidiasis?Richard H Drew
North Carolina Medical Journal|March 9, 2026
A Silent Health Care Emergency: The Disappearance of North Carolina Community PharmaciesRichard H Drew
Pharmacotherapy|November 13, 2004
Key references in infectious diseases pharmacotherapyRichard H Drew,
Pharmacotherapy|January 27, 2007
Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infectionsRichard H Drew
Medical Mycology|July 26, 2008
Aerosol and other novel administrations for prevention and treatment of invasive aspergillosisRichard H Drew
Journal of Fungi (Basel, Switzerland)|February 25, 2022
Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated CementRichard H Drew, John R Perfect
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Antifungal serum concentration monitoring: an updateMegan L Goodwin, Richard H Drew
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 22, 2011
Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infectionsShannon L Holt, Richard H Drew
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Telavancin: a new lipoglycopeptide for gram-positive infectionsWinter J Smith, Richard H Drew
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Managed Care Pharmacy : JMCP|February 25, 2009
Antimicrobial stewardship programs: how to start and steer a successful programRichard H Drew
The Annals of Pharmacotherapy|March 29, 2007
Could risk assessment for non-albicans Candida improve empiric treatment for invasive candidiasis?Richard H Drew
North Carolina Medical Journal|March 9, 2026
A Silent Health Care Emergency: The Disappearance of North Carolina Community PharmaciesRichard H Drew
Pharmacotherapy|November 13, 2004
Key references in infectious diseases pharmacotherapyRichard H Drew,
Pharmacotherapy|January 27, 2007
Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infectionsRichard H Drew
Medical Mycology|July 26, 2008
Aerosol and other novel administrations for prevention and treatment of invasive aspergillosisRichard H Drew
Journal of Fungi (Basel, Switzerland)|February 25, 2022
Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated CementRichard H Drew, John R Perfect
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Antifungal serum concentration monitoring: an updateMegan L Goodwin, Richard H Drew
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 22, 2011
Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infectionsShannon L Holt, Richard H Drew
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Telavancin: a new lipoglycopeptide for gram-positive infectionsWinter J Smith, Richard H Drew
Pageof 5